Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjusted-dose versus usual-dose intrathecal bupivacaine for cesarean section spinal anesthesia
IRCT20120915010841N12Phase 2Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Feb 2019
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of bupivacaine and sufentanil (2 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoints: Complications, Sensory block and 1 more. Started Feb 2019; status: completed.
02
Drugs
bupivacainesufentanil
Beyond the preview
Go deeper on IRCT20120915010841N12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120915010841N12.